Specifically, we sought to assess the impact of very high ( ≥ 90%) and negative PD-L1 TPS levels on disease outcomes, establish TMB as a predictive biomarker in this patient population and to characterize the impact of pneumonitis and its timing on outcomes. The gene discussed is CD274; the disease is pneumonitis.